🇮🇳 Rybrevant in India

Rybrevant (AMIVANTAMAB) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Rybrevant in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in India

Frequently asked questions

Is Rybrevant approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Rybrevant in India?

Johnson & Johnson is the originator. The local marketing authorisation holder may differ — check the official source linked above.